Evidence map›Paper›PMID 41268478›Full record

ArticleBioinformatics advances2025

Exploring SARS-CoV-2 spike protein mutations through genetic algorithm-driven structural modeling.

Valentina Di Salvatore, Avisa Maleki, Babak Mohajer, Alvaro Ras-Carmona, Giulia Russo, Pedro Antonio Reche, Francesco Pappalardo

Abstract read
In one paragraph

Article in Bioinformatics advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Valentina Di SalvatoreDepartment of Drug and Health Sciences, University of Catania, Catania, 95125, Italy.ORCID https://orcid.org/0000-0001-5576-3070
Avisa MalekiDepartment of Drug and Health Sciences, University of Catania, Catania, 95125, Italy.
Babak MohajerMimesis SRL, Catania, 95125, Italy.
Alvaro Ras-CarmonaDepartment of Immunology, Faculty of Medicine, University Complutense of Madrid, Madrid, 28040, Spain.
Giulia RussoDepartment of Drug and Health Sciences, University of Catania, Catania, 95125, Italy.
Pedro Antonio RecheDepartment of Immunology, Faculty of Medicine, University Complutense of Madrid, Madrid, 28040, Spain.ORCID https://orcid.org/0000-0003-3966-5838
Francesco PappalardoDepartment of Drug and Health Sciences, University of Catania, Catania, 95125, Italy.ORCID https://orcid.org/0000-0003-1668-3320

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Motivation: The rapid evolution of SARS-CoV-2 highlights the importance of computational approaches to explore mutational effects on the viral spike protein. In this work, we present a genetic algorithm (GA) framework applied to the structural optimization of spike protein variants, with a focus on energetic and binding properties rather than direct evolutionary prediction. Results: Our GA-driven pipeline generated spike variants with progressively improved structural stability as indicated by lower discrete optimized protein energy scores across generations. The approach also enabled evaluation of Gibbs free energy and binding affinity for spike-Angiotensin-converting enzyme 2 receptor interactions, revealing candidate conformations with favorable thermodynamic properties. These results demonstrate the algorithm's capacity to refine protein models and explore mutational landscapes in silico, although no validation against naturally emerging variants was performed. This study presents a methodological framework for GA-based structural modeling of SARS-CoV-2 spike mutations. Rather than forecasting specific variants of concern, it demonstrates the feasibility of a computational approach that can be extended and integrated with evolutionary and experimental evidence to strengthen future efforts in variant monitoring and vaccine development. Availability and implementation: All the Python and R scripts are available upon request to the authors.

Identifiers

PMID41268478
PMCPMC12627402

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.